School of Influenza 2012 Siena 16 - 20 July 2012 |
Organising Committee
Emanuele Montomoli, University of Siena, Italy
Jackie Katz, Centers for Disease Control and Prevention, Atlanta, USA
John Wood, National Institute for Biological Standards and Control, Hertfordshire, UK - retired
Programme
MONDAY 16 JULY 2012 08.30 - 09.00. Introduction • Emanuele Montomoli (University of Siena, Italy) and John Wood (National Institute for Biological Standards and Control, Hertfordshire, UK - retired): Welcome in Siena and introduction • Jackie Katz (Centers for Disease Control and Prevention, Atlanta, USA): isirv Introduction
09.00 - 11.30. THEME 1: HISTORY, EPIDEMIOLOGY AND ECOLOGY OF INFLUENZA • John Oxford (Retroscreen Virology Ltd): Medical and social impact of pandemics from 1918-2009 • Lyn Finelli (Centers for Disease Control and Prevention, Atlanta, USA): Global influenza epidemiology and surveillance 11.30 - 13.00. SPECIAL SEMINAR • Rino Rappuoli (Novartis Vaccines and Diagnostics, Siena, Italy): Vaccination: past, present and future 14.30 - 15.30. SPECIAL TOPIC • Angus Nicoll (European Centre for Disease Prevention and Control, Stockolm, Sweden): Lessons learned from the Pandemic 2009 – the ECDC Perspective 15.30 - 17.30. THEME 1: HISTORY, EPIDEMIOLOGY AND ECOLOGY OF INFLUENZA (continued) • Giovanni Cattoli (Istituto Zooprofilattico Sperimentale delle Venezie, Padova, Italy): Animal influenza 17.30 - 19.00. Students' presentations: Vina Arguelles (Department of Health, The Philippines); Samanta Etel Treiger Borborema (Adolfo Lutz Institute, Sao Paulo, Brazil); Eeva Broberg (European Centre for Disease Prevention and Control, Stockolm, Sweden); Clément Meseko (University of Ibadan, Nigeria); Martine Etschmeier (Baxter International Inc.); Ellen Fragaszy (University College, London, UK) TUESDAY 17 JULY 2012 09.00 - 13.00: THEME 2: PREVENTION AND CONTROL • Olav Hungnes (Norwegian Institute of Public Health, Oslo, Norway): Virological diagnosis and surveillance • Jonathan Van Tam (University of Nottingham, UK): Influenza disease burden and vaccination policies • John Treanor (University of Rochester Medical Center, USA): Effectiveness of vaccines and antivirals
• Sylvie Van der Werf (Institut Pasteur, Paris, France): Virus structure and replication • Hans Dieter Klenk (University of Marburg, Germany): Pathogenesis and host range • Wendy Barclay (Imperial College, London, UK): Transmissibility and the influence of the host
09.00 - 10.30. THEME 3: INFLUENZA VIROLOGY AND PATHOGENESIS (continued) • Karl G. Nicholson (University of Leicester, UK): Influenza disease and management in humans
• Jackie Katz (Centers for Disease Control and Prevention, Atlanta, USA): The immune response to influenza infection • Rebecca J. Cox (University of Bergen, Norway): Immune correlates of protection against influenza 14.30 - 18.30. THEME 5: INFLUENZA VACCINES • Otfried Kistner (Baxter Innovation GmbH): Inactivated vaccines • John Treanor (University of Rochester Medical Center, USA): Live attenuated vaccines • Nathalie Landry (Médicago Inc., Québec, Canada): Plant-based influenza vaccines THURSDAY 19 JULY 2012
09.00 - 13.00. THEME 6: ANTIVIRALS AND OTHER THERAPIES • Anna Teresa Palamara (Sapienza University of Rome, Italy): Redox-regulated intracellular pathways as new potential targets for anti-influenza drugs • David S. Fedson (Sergy Haut, France): Treating the host response in severe disease • Alan Hay (National Institute for Medical Research, London, UK): Influenza antivirals
• Leonoor Wijnans (Medicines Evaluation Board, The Netherlands): Regulatory challenges for influenza vaccines
09.00-10.30. THEME 7: REGULATORY PRACTICES AND CHALLENGES (continued) • John Wood (National Institute for Biological Standards and Control, Hertfordshire, UK - retired), Licensing requirements and the importance of standardisation 10.30-12.30. THEME 5: INFLUENZA VACCINES (continued) • Alan Shaw (VaxInnate Corporation, Cranbury, USA): New vaccine technologies • 12.30 - 13.00 CLOSING REMARKS
AcknowledgementsThe Summer School of Influenza – 2nd edition has been organized with the generous support of the isirv – International Society for Influenza and other Respiratory Virus Diseases.
|